Beijing Polypeptide Bio Logo
Home/News Center/Now Live | Beijing Peptide Biotechnology Unveils New Global Website, Launching a Digital Gateway for Worldwide Peptide Technology Services
Return News List

Now Live | Beijing Peptide Biotechnology Unveils New Global Website, Launching a Digital Gateway for Worldwide Peptide Technology Services

2026-07-30
Company News

Published: 2026/07/30

Source: Beijing Peptide Biotechnology Co., Ltd.

Recently, Beijing Polypeptide Biotechnology Co., Ltd. launched its brand-new official website (https://www.peptide-bio.com/) is officially relaunching. The new website rebuilds our digital service system around over 20 years of core strengths in peptide R&D and manufacturing, integrating custom peptide synthesis, research peptides, and GMP-grade production.A one-stop online platform for peptide technology services, offering end-to-end solutions in pharmaceutical intermediates and non-natural amino acid synthesis. Designed for global pharmaceutical companies, biotech firms, universities, and research institutes to deliver clearer insights, streamlined service, and more efficient communication.

Beijing PolyPeptide Bio has been dedicated to the R&D and production of peptide drugs for over 20 years. Our professional team of more than 100 experts has overcome technical barriers in synthesizing long-chain peptides with up to 180 amino acids, enabling scalable manufacturing from milligram to kilogram levels. We operate a standardized production base covering 3000㎡, fully compliant with ICH Q7 and cGMP standards. Our capabilities span the entire value chain—from early-stage custom R&D to commercial-scale compliant manufacturing—serving thousands of biopharmaceutical partners both domestically and internationally. Driven by the growing global demand for peptide drugs, antimicrobial peptides, hormone peptides, neuropeptides, and peptides for diabetes and oncology treatments, our existing website no longer supports our global business expansion, full-service CDMO portfolio, or efficient client engagement. This comprehensive site overhaul is therefore launched to meet these evolving needs.

The new website has been comprehensively optimized around customer use cases. Key highlights include:

Clear business segmentation with transparent display of technical capabilities

Four core business areas for the website redesign: Custom Research Peptides, Catalog Peptides in Stock, GMP-Compliant Pharmaceutical Peptide Intermediates, and Non-Natural Amino Acid Synthesis Services. These sections comprehensively showcase specialized technologies including complex modifications, fluorescent labeling, PEGylation, and heterocyclic small-molecule building blocks. The platform clearly distinguishes between laboratory-scale development and commercial manufacturing services, enabling customers to quickly align with their specific R&D stage needs.

Visualize Compliance and Production Capacity Advantages

A dedicated Quality & Compliance section fully discloses our cGMP-standardized production lines, end-to-end quality control and testing systems, ICH international quality standards, and NDA-based intellectual property confidentiality protocols. It also highlights our rapid delivery capabilities: standard custom peptides delivered in 2-3 weeks, with small research orders completed as fast as 1 weeks—clearly demonstrating our scalable manufacturing strength and rigorous quality control.

Three convenient service entry points to streamline customer communication

Direct access from the homepage to three key service channels: Quote Request, Deep Project Collaboration, and Technical Consulting. Submit your peptide sequence and production scale for an instant custom quote; get expert answers on synthesis, modification, and process development from our PhD-level technical team online; and open a channel for deep collaboration on new peptide drug R&D and GMP-scale commercialization, with a dedicated project manager providing one-on-one support throughout the project.

Global Adaptation and Comprehensive Brand Content Update

Fully responsive across desktop and mobile devices with synchronized bilingual content updates. Refreshed company profile, R&D capabilities, client case studies, and technical white papers to showcase our global partnerships with research institutions and multinational pharmaceutical companies, highlighting the international service excellence of a domestic peptide CDMO leader.

The company representative stated: "Our new website serves as the digital gateway for Beijing Peptide Biotech to engage with global customers. For over two decades, we have remained dedicated to peptide technology innovation. This redesign goes beyond a visual upgrade—it represents a comprehensive enhancement of our service workflows, technical showcases, and client engagement systems. Moving forward, we will leverage this new platform to continuously deliver core competencies in long-chain peptide synthesis and compliant pharmaceutical intermediate manufacturing, providing transparent, efficient, and professional online services to become a trusted, integrated partner in the global peptide R&D sector."

Next, Beijing Peptide Biotech will leverage its newly launched website to continuously update technical news in the peptide industry, showcase new drug development case studies, and share process solutions. The site will also introduce online sample requests and downloadable process documentation, further enhancing its digital service ecosystem to accelerate the transition of peptide innovative drugs from the laboratory to commercial production.

About Beijing Polypeptide Biotechnology Co., Ltd.

Beijing Polypeptide Bio is a leading technology-driven company in the research, development, and production of peptide drugs. With over 20 years of expertise in the peptide field, we specialize in custom peptide synthesis, production of peptide drug intermediates, and research-grade peptide services. Our capabilities include ultra-long peptide synthesis with up to 180+ amino acids, with production capacity ranging from milligrams to kilograms. We maintain a comprehensive quality control and intellectual property protection system, serving pharmaceutical companies, universities, and research institutes worldwide. We provide end-to-end, full-chain peptide solutions—from R&D customization and clinical development to commercial-scale manufacturing.

Consultation Support

Official website:https://www.peptide-bio.com/

Business Hotline: 18519923863

Email: 18519923863@163.com